🔬 Discover how #immunology is transforming cancer treatment! Our joint virtual issue on Cancer Immunology & Immunotherapy highlights cutting-edge research shaping the future of #CancerTherapies.
www.immunology.org/publications...
#CancerResearch
#WorldCancerDay
www.immunology.org/publications...
#CancerResearch
#WorldCancerDay
Cancer immunology and immunotherapy Virtual Issue | British Society for Immunology
www.immunology.org
February 4, 2025 at 11:26 AM
🔬 Discover how #immunology is transforming cancer treatment! Our joint virtual issue on Cancer Immunology & Immunotherapy highlights cutting-edge research shaping the future of #CancerTherapies.
www.immunology.org/publications...
#CancerResearch
#WorldCancerDay
www.immunology.org/publications...
#CancerResearch
#WorldCancerDay
👏 Thomas Vogl, Center for #CancerResearch at #MedUniVienna, has been accepted into the Young Investigator Programme by @embo.org!
He is investigating how the gut microbiome and #immunesystem together influence the success of #cancertherapies. ⬇️
He is investigating how the gut microbiome and #immunesystem together influence the success of #cancertherapies. ⬇️
Thomas Vogl accepted into EMBO Young Investigator Programme
Read more about his research!
www.meduniwien.ac.at
December 5, 2025 at 8:59 AM
👏 Thomas Vogl, Center for #CancerResearch at #MedUniVienna, has been accepted into the Young Investigator Programme by @embo.org!
He is investigating how the gut microbiome and #immunesystem together influence the success of #cancertherapies. ⬇️
He is investigating how the gut microbiome and #immunesystem together influence the success of #cancertherapies. ⬇️
We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.
September 12, 2025 at 12:04 AM
We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.
#Medsky🧪#Oncosky #publichealth Premenopausal women are more likely than men to develop certain cancers. Pathways activated by the sex hormone responsible could be targeted in #cancertherapies.
@nature.com
www.nature.com/articles/d41...
PDF
www.nature.com/articles/d41...
@nature.com
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Sex differences in skin-cancer risk are linked to oestrogen levels
Premenopausal women are more likely than men to develop certain cancers. Pathways activated by the sex hormone responsible could be targeted in cancer therapies.
www.nature.com
June 18, 2025 at 8:36 AM
#Medsky🧪#Oncosky #publichealth Premenopausal women are more likely than men to develop certain cancers. Pathways activated by the sex hormone responsible could be targeted in #cancertherapies.
@nature.com
www.nature.com/articles/d41...
PDF
www.nature.com/articles/d41...
@nature.com
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Lisa Steinhelfer and Friederike Jungmann found that certain #cancertherapies can cause early #kidneydamage, detectable via #AI-analyzed #CTscans. This allows timely treatment adjustments: go.tum.de/787388
#cancertreatment #kidneyfunction
📷A.Eckert
#cancertreatment #kidneyfunction
📷A.Eckert
AI-based image analysis detects early organ damage
Early warning through AI image analysis: Long before kidney damage occurs as a result of some prostate cancer therapies, kidney volume is slightly reduced.
go.tum.de
April 29, 2025 at 2:07 PM
Lisa Steinhelfer and Friederike Jungmann found that certain #cancertherapies can cause early #kidneydamage, detectable via #AI-analyzed #CTscans. This allows timely treatment adjustments: go.tum.de/787388
#cancertreatment #kidneyfunction
📷A.Eckert
#cancertreatment #kidneyfunction
📷A.Eckert
This new review shows that mechanical forces, like fluid shear stress, in the #TumorMicroenvironment shape #Angiogenesis and #vascular behavior, offering novel strategies for normalizing #tumor cells and unique #CancerTherapies. #medsky
#OpenAccess:
www.sciencedirect.com/science/arti...
#OpenAccess:
www.sciencedirect.com/science/arti...
August 27, 2025 at 12:30 PM
This new review shows that mechanical forces, like fluid shear stress, in the #TumorMicroenvironment shape #Angiogenesis and #vascular behavior, offering novel strategies for normalizing #tumor cells and unique #CancerTherapies. #medsky
#OpenAccess:
www.sciencedirect.com/science/arti...
#OpenAccess:
www.sciencedirect.com/science/arti...
Huge congratulations to @pancreaticcanuk.bsky.social for an incredible event fostering real dialogue between lab and clinical researchers. Great panel discussions on the major challenges (bench/ bedside) and how to bridge science and patient diversity for better #PancreaticCancer #CancerTherapies.
November 7, 2025 at 6:01 PM
Huge congratulations to @pancreaticcanuk.bsky.social for an incredible event fostering real dialogue between lab and clinical researchers. Great panel discussions on the major challenges (bench/ bedside) and how to bridge science and patient diversity for better #PancreaticCancer #CancerTherapies.
We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.
September 10, 2025 at 10:38 PM
We are excited to announce #NDLR2026 speaker, clinician-scientist Prof Rishi Kotecha from the Kids Research Institute. His research aims to develop novel #CancerTherapies for #ChildhoodCancer. He is also leading #ClinicalTrails to improve outcomes for children with #Leukemia.
Researchers found that certain #immunecells can trigger healing in the gut after #cancertherapies using #inflammatory signals – a surprising result, since #gutinflammation was long seen as mainly harmful: go.tum.de/772318
📷J.Fischer
📷J.Fischer
Immune cells turn damage into repair
Researchers discovered that immune cells trigger healing processes in the event of damage to the intestine, for example after radiation therapy.
go.tum.de
November 27, 2025 at 3:17 PM
Researchers found that certain #immunecells can trigger healing in the gut after #cancertherapies using #inflammatory signals – a surprising result, since #gutinflammation was long seen as mainly harmful: go.tum.de/772318
📷J.Fischer
📷J.Fischer
Interesting work to which our institute actively contributed
#cancertherapies #bioinformatics
www.nature.com/articles/s41...
#cancertherapies #bioinformatics
www.nature.com/articles/s41...
Learning and actioning general principles of cancer cell drug sensitivity - Nature Communications
Potential anti-tumor therapies remain to be discovered in cancer cell line high-throughput screening datasets. Here, the authors develop a machine learning approach to infer cancer cell drug sensitivi...
www.nature.com
February 18, 2025 at 1:07 PM
Interesting work to which our institute actively contributed
#cancertherapies #bioinformatics
www.nature.com/articles/s41...
#cancertherapies #bioinformatics
www.nature.com/articles/s41...
Jennifer Altomonte and her team at Fusix Biotech, a spin-off from our university, are developing virus-based #cancertherapies that mobilize the body’s own #immunedefenses in the fight against the disease: go.tum.de/312166
#ImmunoTherapy
📷J. Eberle
#ImmunoTherapy
📷J. Eberle
A therapeutic virus against cancer
Fusix Biotech, a spin-off from the Technical University of Munich (TUM) develops virus-based cancer therapies that mobilize the body’s own immune defenses.
go.tum.de
June 4, 2025 at 2:44 PM
Jennifer Altomonte and her team at Fusix Biotech, a spin-off from our university, are developing virus-based #cancertherapies that mobilize the body’s own #immunedefenses in the fight against the disease: go.tum.de/312166
#ImmunoTherapy
📷J. Eberle
#ImmunoTherapy
📷J. Eberle
📣 ICYMI: #StanDOM's 2025 Annual Report is now live. From new #CancerTherapies to faster #sepsis diagnostics & an innovative transplant program, this year's report highlights inspiring moments that drive our momentum forward. https://stanford.io/4hq25BJ
October 27, 2025 at 7:11 PM
📣 ICYMI: #StanDOM's 2025 Annual Report is now live. From new #CancerTherapies to faster #sepsis diagnostics & an innovative transplant program, this year's report highlights inspiring moments that drive our momentum forward. https://stanford.io/4hq25BJ
#ESMOBreast26 Award recipient Daniel F. Hayes, describes how his career was shaped by milestone discoveries in #BreastCancer and how #Biomarker research is evolving treatment with promising new #CancerTherapies. Read more
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
May 6, 2026 at 11:30 AM
#ESMOBreast26 Award recipient Daniel F. Hayes, describes how his career was shaped by milestone discoveries in #BreastCancer and how #Biomarker research is evolving treatment with promising new #CancerTherapies. Read more
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
Amazing News #Cancer #CancerTherapies #Science Save Science, Get Rid of Brainworm Rot! Breakthrough in Treating Pancreatic Cancer!
youtube.com/shorts/JK6yF...
youtube.com/shorts/JK6yF...
A major breakthrough in cancer treatment! #cancer #medication #doctor
YouTube video by Dr. Zachary Rubin
youtube.com
June 1, 2026 at 9:41 PM
Amazing News #Cancer #CancerTherapies #Science Save Science, Get Rid of Brainworm Rot! Breakthrough in Treating Pancreatic Cancer!
youtube.com/shorts/JK6yF...
youtube.com/shorts/JK6yF...
Researchers from @isbscience.org are using generative AI to unlock new understanding of human immunity. These discoveries could help predict disease severity and improve #CancerTherapies.
🤔 Learn about TARPON, created by Dr. Jim Heath and Daniel Chen: bit.ly/4kjTAb5
🤔 Learn about TARPON, created by Dr. Jim Heath and Daniel Chen: bit.ly/4kjTAb5
July 7, 2025 at 10:32 PM
Researchers from @isbscience.org are using generative AI to unlock new understanding of human immunity. These discoveries could help predict disease severity and improve #CancerTherapies.
🤔 Learn about TARPON, created by Dr. Jim Heath and Daniel Chen: bit.ly/4kjTAb5
🤔 Learn about TARPON, created by Dr. Jim Heath and Daniel Chen: bit.ly/4kjTAb5
浩鼎自創ADC平台GlycOBI® 首宗技術合作案🤝
OBI Pharma Enters ADC Collaboration with Tegmine Therapeutics! 🤝 🚀
#OBIPharma #TegMineTherapeutics #ADCCollaboration #GlycOBI #CancerTherapies
🔬 Learn more:
📄 English Press Release: lnkd.in/gprWcZ7D
📄 中文新聞稿: lnkd.in/gqEqredN
OBI Pharma Enters ADC Collaboration with Tegmine Therapeutics! 🤝 🚀
#OBIPharma #TegMineTherapeutics #ADCCollaboration #GlycOBI #CancerTherapies
🔬 Learn more:
📄 English Press Release: lnkd.in/gprWcZ7D
📄 中文新聞稿: lnkd.in/gqEqredN
lnkd.in
June 6, 2025 at 7:17 AM
浩鼎自創ADC平台GlycOBI® 首宗技術合作案🤝
OBI Pharma Enters ADC Collaboration with Tegmine Therapeutics! 🤝 🚀
#OBIPharma #TegMineTherapeutics #ADCCollaboration #GlycOBI #CancerTherapies
🔬 Learn more:
📄 English Press Release: lnkd.in/gprWcZ7D
📄 中文新聞稿: lnkd.in/gqEqredN
OBI Pharma Enters ADC Collaboration with Tegmine Therapeutics! 🤝 🚀
#OBIPharma #TegMineTherapeutics #ADCCollaboration #GlycOBI #CancerTherapies
🔬 Learn more:
📄 English Press Release: lnkd.in/gprWcZ7D
📄 中文新聞稿: lnkd.in/gqEqredN
Can smarter #GeneDelivery unlock the full potential of #CancerTherapies?
This review explores how #nanoplexes enhance nucleic acid delivery, offering safer and more efficient strategies for targeted cancer therapies.
#OpenAccess in #NanotechnologyReviews: doi.org/10.1515/ntre...
This review explores how #nanoplexes enhance nucleic acid delivery, offering safer and more efficient strategies for targeted cancer therapies.
#OpenAccess in #NanotechnologyReviews: doi.org/10.1515/ntre...
August 21, 2026 at 7:00 AM
Can smarter #GeneDelivery unlock the full potential of #CancerTherapies?
This review explores how #nanoplexes enhance nucleic acid delivery, offering safer and more efficient strategies for targeted cancer therapies.
#OpenAccess in #NanotechnologyReviews: doi.org/10.1515/ntre...
This review explores how #nanoplexes enhance nucleic acid delivery, offering safer and more efficient strategies for targeted cancer therapies.
#OpenAccess in #NanotechnologyReviews: doi.org/10.1515/ntre...
ICYMI: LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!
Public Health Weekly News – July 4th 2025
Public Health Update : Meat, Soda Risks; AI Beats Doctors; Tick-Borne Allergy and More 🔬 From game-changing cancer treatments to […]
The post Public Health Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.
dlvr.it
July 5, 2025 at 11:18 AM
ICYMI: LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!
FYI: LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!
Public Health Weekly News – July 4th 2025
Public Health Update : Meat, Soda Risks; AI Beats Doctors; Tick-Borne Allergy and More 🔬 From game-changing cancer treatments to […]
The post Public Health Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.
dlvr.it
July 12, 2025 at 11:20 AM
FYI: LucidQuest Views >>> Public Health Weekly News – July 4th 2025 #News #cancertherapies #airpollution Comment below!
Lipid imbalances hold the key to chronic inflammation in colon cancer 🔬🧬🌿 www.news-medical.net/news/2024121... #LipidMetabolism #ColorectalCancer #ChronicInflammation #Cancer #Tumors #Inflammation #CancerTherapies #PrecisionMedicine #Gut #Health
Lipid imbalances hold the key to chronic inflammation in colon cancer
Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new therapeutic strategies targeting pro-inflammatory and pro-resolving lipid ...
www.news-medical.net
December 13, 2024 at 1:30 AM
Lipid imbalances hold the key to chronic inflammation in colon cancer 🔬🧬🌿 www.news-medical.net/news/2024121... #LipidMetabolism #ColorectalCancer #ChronicInflammation #Cancer #Tumors #Inflammation #CancerTherapies #PrecisionMedicine #Gut #Health
#DrugResistance can undermine even effective #CancerTherapies.
This review spotlights losartan, a common antihypertensive, as a repurposed agent that remodels the #TumorMicroenvironment to enhance chemotherapy delivery & reverse resistance.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This review spotlights losartan, a common antihypertensive, as a repurposed agent that remodels the #TumorMicroenvironment to enhance chemotherapy delivery & reverse resistance.
#GenesAndDiseases: doi.org/10.1016/j.ge...
August 14, 2026 at 3:19 PM
#DrugResistance can undermine even effective #CancerTherapies.
This review spotlights losartan, a common antihypertensive, as a repurposed agent that remodels the #TumorMicroenvironment to enhance chemotherapy delivery & reverse resistance.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This review spotlights losartan, a common antihypertensive, as a repurposed agent that remodels the #TumorMicroenvironment to enhance chemotherapy delivery & reverse resistance.
#GenesAndDiseases: doi.org/10.1016/j.ge...
Better #CancerTherapies require new ways to eliminate tumor cells.
This review highlights #disulfidptosis as an emerging form of regulated cell death with strong potential as a #biomarker and therapeutic target in cancer.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This review highlights #disulfidptosis as an emerging form of regulated cell death with strong potential as a #biomarker and therapeutic target in cancer.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
August 9, 2026 at 3:06 PM
Better #CancerTherapies require new ways to eliminate tumor cells.
This review highlights #disulfidptosis as an emerging form of regulated cell death with strong potential as a #biomarker and therapeutic target in cancer.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This review highlights #disulfidptosis as an emerging form of regulated cell death with strong potential as a #biomarker and therapeutic target in cancer.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
"The new findings will contribute to ongoing basic studies in polymerases theta and delta, while also aiding new cancer drugs called polymerase theta inhibitors, which are currently in clinical trials."
www.genengnews.com/topics/cance...
#dnarepair #cancertherapies
www.genengnews.com/topics/cance...
#dnarepair #cancertherapies
November 20, 2023 at 3:27 PM
"The new findings will contribute to ongoing basic studies in polymerases theta and delta, while also aiding new cancer drugs called polymerase theta inhibitors, which are currently in clinical trials."
www.genengnews.com/topics/cance...
#dnarepair #cancertherapies
www.genengnews.com/topics/cance...
#dnarepair #cancertherapies
#AstraZeneca #PascalSoriot #cancertherapies #oncologyproducts #commercialperformance #blockbusterbrands #cancer #weightloss #genetherapies #antiHER2therapy #prostatecancer #breastcancer #asthma #respiratorysyncytialvirus #RSV #RSVprophylactic #lupus #phase2trials #phase3trials
zurl.co/yLEDf
zurl.co/yLEDf
AstraZeneca raises guidance on stellar cancer drugs growth
AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron
pharmaphorum.com
February 16, 2026 at 2:36 PM